ClassID:

92612

C07C219/10 - CPC Classification

Classification description:

Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to an acyclic carbon atom of a carbon skeleton containing rings

Recent Application in this class:
#1
20250281452
2025-09-11

CHIRAL ARYL PROPIONIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF, AND USE

#2
20250034081
2025-01-30

NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS

#3
20250009659
2025-01-09

DEVELOPMENT OF A NEW FAMILY OF NANOCARRIERS DERIVED FROM NATURAL TETRAMERIC ACID LIPIDS

#4
20240156770
2024-05-16

HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOID-RELATED COMPOUNDS

#5
20240115511
2024-04-11

NANOMATERIALS COMPRISING AN IONIZABLE LIPID

#6
20240002409
2024-01-04

Method for producing triarylorganoborates

#7
20230202966
2023-06-29

ACYCLIC LIPIDS AND METHODS OF USE THEREOF

#8
20220064157
2022-03-03

High penetration drugs and their compositions thereof for treatment of Parkinson diseases

#9
20220002321
2022-01-06

Method for producing triarylorganoborates

#10
20210196664
2021-07-01

High penetration prodrug compositions of retinoids and retinoids-related compounds

#11
20210107861
2021-04-15

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

#12
20190270697
2019-09-05

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

#13
20190263838
2019-08-29

Method for producing triarylorganoborates

#14
20170334908
2017-11-23

High penetration drugs and their compositions thereof for treatment of Parkinson diseases

#15
20170098772
2017-04-06

Process of manufacturing an electron transport material

#16
20160002157
2016-01-07

High penetration drugs and their compositions thereof for treatment of parkinson diseases

#17
20150376115
2015-12-31

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

#18
20140315960
2014-10-23

Prodrugs of non-steroid anti-inflammatory agents (NSAIDS)

#19
20110251158
2011-10-13

FULLERENE THERAPIES FOR INFLAMMATION AND INHIBITION OF BUILD-UP OF ARTERIAL PLAQUE

#20
20100239516
2010-09-23

Poly cationic compounds

#21
20100228015
2010-09-09

PRODRUG DERIVATIVES OF ACIDS USING ALCOHOLS WITH HOMOTOPIC HYDROXY GROUPS AND METHODS FOR THEIR PREPARATION AND USE

#22
20100010084
2010-01-14

High penetration prodrug compositions of retinoids and retinoid-related compounds

#23
20070276138
2007-11-29

Modulators of peroxisome proliferator activated receptors

#24
20070254920
2007-11-01

Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

#25
20070129397
2007-06-07

Ester derivatives

#26
20050065211
2005-03-24

Ester derivatives

#27
20050020684
2005-01-27

Modulators of peroxisome proliferator activated receptors